Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-16-032337
Filing Date
2016-10-27
Accepted
2016-10-27 10:45:15
Documents
1
Period of Report
2016-10-26

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 4565
  Complete submission text file 0000899243-16-032337.txt   6201
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM 11 (441) 824-8101
Myovant Sciences Ltd. (Issuer) CIK: 0001679082 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152
Business Address THURGAUERSTRASSE 130 GLATTPARK-OPFIKON ZURICH V8 8152 41-44-555-10-00
Takeda Pharmaceuticals International AG (Reporting) CIK: 0001688140 (see all company filings)

State of Incorp.: V8 | Fiscal Year End: 0331
Type: 3/A | Act: 34 | File No.: 001-37929 | Film No.: 161954318